Tina H Chiang

Summary

Affiliation: Allergan Inc
Country: USA

Publications

  1. ncbi request reprint Real-world utilization patterns of cyclosporine ophthalmic emulsion 0.05% within managed care
    Tina H Chiang
    Allergan Inc, Irvine, CA, USA
    Can J Clin Pharmacol 14:e240-5. 2007
  2. ncbi request reprint Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis
    John G Walt
    Allergan, Inc, Irvine, California 92612, USA
    Clin Drug Investig 27:819-25. 2007
  3. ncbi request reprint Efficiency of instillation methods for prostaglandin medications
    Richard Fiscella
    Department of Ophthalmology, University of Chicago, Chicago, IL 60612, USA
    J Ocul Pharmacol Ther 22:477-82. 2006
  4. ncbi request reprint A gap analysis approach to assess patient persistence with glaucoma medication
    Paul P Lee
    Duke Eye Center, Duke University, Durham, North Carolina, USA
    Am J Ophthalmol 144:520-4. 2007
  5. ncbi request reprint Determinants of uncontrolled hypertension in an African-American population
    James H Jackson
    Applied Health Outcomes, Division of Navigant Consulting, Inc, Tampa, Florida 33609, USA
    Ethn Dis 12:S3-53-7. 2002
  6. ncbi request reprint The impact of glaucoma coding in a large claims database
    Paul P Lee
    Duke University Eye Center, Durham, North Carolina, USA
    Am J Ophthalmol 143:867-70. 2007
  7. ncbi request reprint Direct costs of blindness experienced by patients enrolled in managed care
    Kevin D Frick
    Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
    Ophthalmology 115:11-7. 2008
  8. ncbi request reprint Health care charges for patients with ocular hypertension or primary open-angle glaucoma
    Louis R Pasquale
    Glaucoma Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA
    Ophthalmology 115:633-638.e4. 2008
  9. ncbi request reprint The prevalence of glaucomatous risk factors in patients from a managed care setting: a pilot evaluation
    Ervin N Fang
    Southern California Kaiser Permanente Medical Group, 1515 N Vermont Ave, 7A, Los Angeles, CA 90027, USA
    Am J Manag Care 14:S28-36. 2008

Detail Information

Publications9

  1. ncbi request reprint Real-world utilization patterns of cyclosporine ophthalmic emulsion 0.05% within managed care
    Tina H Chiang
    Allergan Inc, Irvine, CA, USA
    Can J Clin Pharmacol 14:e240-5. 2007
    ..Cyclosporine 0.05% ophthalmic emulsion (Restasis) is a treatment for dry eye disease...
  2. ncbi request reprint Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis
    John G Walt
    Allergan, Inc, Irvine, California 92612, USA
    Clin Drug Investig 27:819-25. 2007
    ..This study aimed to determine the average number of days between refills for latanoprost, travoprost and bimatoprost, and to estimate the potential effect of differences in refill rates on pharmacy budgets...
  3. ncbi request reprint Efficiency of instillation methods for prostaglandin medications
    Richard Fiscella
    Department of Ophthalmology, University of Chicago, Chicago, IL 60612, USA
    J Ocul Pharmacol Ther 22:477-82. 2006
    ..The aim of this study was to determine the most efficient methods for instillation of prostaglandin analogs...
  4. ncbi request reprint A gap analysis approach to assess patient persistence with glaucoma medication
    Paul P Lee
    Duke Eye Center, Duke University, Durham, North Carolina, USA
    Am J Ophthalmol 144:520-4. 2007
    ..To develop an alternative method for analysis of patient persistence with prescribed medications using the prostaglandin class of intraocular pressure (IOP)-lowering drugs as a model...
  5. ncbi request reprint Determinants of uncontrolled hypertension in an African-American population
    James H Jackson
    Applied Health Outcomes, Division of Navigant Consulting, Inc, Tampa, Florida 33609, USA
    Ethn Dis 12:S3-53-7. 2002
    ..The purpose of this study was to assess blood pressure control and the determinants of uncontrolled blood pressure among African-American hypertensive patients...
  6. ncbi request reprint The impact of glaucoma coding in a large claims database
    Paul P Lee
    Duke University Eye Center, Durham, North Carolina, USA
    Am J Ophthalmol 143:867-70. 2007
    ..We assessed potential differences in demographics and healthcare charges among patients with open-angle glaucoma identified through different International Classification of Diseases, Ninth Revision (ICD-9) coding algorithms...
  7. ncbi request reprint Direct costs of blindness experienced by patients enrolled in managed care
    Kevin D Frick
    Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
    Ophthalmology 115:11-7. 2008
    ..To evaluate total and condition-related charges incurred by blind patients in a managed care population in the United States and compare total charges with those of a matched nonblind cohort...
  8. ncbi request reprint Health care charges for patients with ocular hypertension or primary open-angle glaucoma
    Louis R Pasquale
    Glaucoma Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA
    Ophthalmology 115:633-638.e4. 2008
    ..To determine the total and condition-related direct health care charges of patients with ocular hypertension (OH) or primary open-angle glaucoma (POAG) and identify factors that affect these charges...
  9. ncbi request reprint The prevalence of glaucomatous risk factors in patients from a managed care setting: a pilot evaluation
    Ervin N Fang
    Southern California Kaiser Permanente Medical Group, 1515 N Vermont Ave, 7A, Los Angeles, CA 90027, USA
    Am J Manag Care 14:S28-36. 2008
    ....